Professional Documents
Culture Documents
Blue Ocean Strategy For Medical and Pharmaceuticals
Blue Ocean Strategy For Medical and Pharmaceuticals
Blue Ocean Strategy For Medical and Pharmaceuticals
net/publication/348728505
CITATIONS READS
0 29
1 author:
SEE PROFILE
Some of the authors of this publication are also working on these related projects:
All content following this page was uploaded by Shahzadah Nayyar Jehan on 24 January 2021.
Dr. JEHAN S. N.
Professor
Tohoku Koeki Bunka University, Japan
Director
Research Center for New Business Strategies
From Functionality to Lifestyle
Listed Equity
Private equity
Venture capital
Business
angels
Unscaled
Typical Private Equity Structure
Source: Gilligan, J. and Wright, M. (2010) Private Equity Demystified, Corporate Finance Faculty of the ICAEW.
PE Transactions
LBO leveraged buyout – can be any of the following
Negotiate
the deal
Find
Make the Manage the
investments Exit
investment investment
Due
diligence
13
Why New M&P Investment Model
This initial shifting of PPV from PPVo to PPV1 will open up two
possibilities i.e.
OR
Also, as
(αβ x αT2) x ½ > (P1T1 x βT1) x ½
NNs for Value Enhancement
M&P & RISK Dispersion
PE & Unconventional Investments
PE deal structure allows: